Literature DB >> 26436031

Dermatofibrosarcoma Protuberans of Lumbar Region with Metastasis to Lung: A Rare Presentation.

Anil Khurana1, Vijay Kumar J2, Paramjeet Kaur3, Ashok K Chauhan4, Gajender Singh5.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a cutaneous slow growing soft tissue sarcoma associated with a high local recurrence rate. Common site of presentation is trunk followed by proximal extremity and head and neck region. A case of recurrent DFSP of left lumbar region with metastasis in lung in a 50-year-old woman presented here. Absence of symptoms often leads to a delay in diagnosis. DFSP is often mistaken for other skin conditions, particularly in its early stages.

Entities:  

Keywords:  Chemotherapy; Cutaneous tumour; Recurrence; Soft tissue sarcoma

Year:  2015        PMID: 26436031      PMCID: PMC4576625          DOI: 10.7860/JCDR/2015/12051.6337

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Using imatinib as neoadjuvant therapy in dermatofibrosarcoma protuberans: potential pluses and minuses.

Authors:  Hillary Johnson-Jahangir; William Sherman; Désirée Ratner
Journal:  J Natl Compr Canc Netw       Date:  2010-08       Impact factor: 11.908

2.  Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients.

Authors:  Delphine Kérob; Raphael Porcher; Olivier Vérola; Stephane Dalle; Eve Maubec; François Aubin; Michel D'Incan; Isaak Bodokh; Serge Boulinguez; Isabelle Madelaine-Chambrin; Anne Mathieu-Boue; Jean-Marie Servant; Eric de Kerviler; Anne Janin; Fabien Calvo; Florence Pedeutour; Celeste Lebbe
Journal:  Clin Cancer Res       Date:  2010-05-03       Impact factor: 12.531

3.  Surgical treatment of dermatofibrosarcoma protuberans.

Authors:  E J Arnaud; M Perrault; M Revol; J M Servant; P Banzet
Journal:  Plast Reconstr Surg       Date:  1997-09       Impact factor: 4.730

4.  Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.

Authors:  Katherine O Castle; B Ashleigh Guadagnolo; C Jillian Tsai; Barry W Feig; Gunar K Zagars
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-04-26       Impact factor: 7.038

Review 5.  Dermatofibrosarcoma protuberans.

Authors:  William M Mendenhall; Robert A Zlotecki; Mark T Scarborough
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

6.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

7.  Evaluation of the role of radiotherapy in the management of dermatofibrosarcoma protuberans.

Authors:  B Uysal; O Sager; H Gamsiz; A Cicek; S Demiral; F Dincoglan; S Surenkok; M Demiriz; M Beyzadeoglu
Journal:  J BUON       Date:  2013 Jan-Mar       Impact factor: 2.533

Review 8.  A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans.

Authors:  H M Gloster; K R Harris; R K Roenigk
Journal:  J Am Acad Dermatol       Date:  1996-07       Impact factor: 11.527

9.  Surgical treatment of dermatofibrosarcoma protuberans.

Authors:  D F Roses; Q Valensi; G LaTrenta; M N Harris
Journal:  Surg Gynecol Obstet       Date:  1986-05

10.  Imatinib in the treatment of dermatofibrosarcoma protuberans.

Authors:  Stefanos V Labropoulos; Evangelia D Razis
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.